Q5128 Injection, cimerli, 0.1 milligrams
Q-Codes
Also known as: Cimerli injection, pembrolizumab-cmkc
Injection of Cimerli, pembrolizumab-cmkc biosimilar per 0.1 milligrams, a programmed cell death receptor-1 inhibitor.
Clinical Context
Used for various cancers including melanoma, lung cancer, and head and neck cancers.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.